Ferrer-García, Juan Carlos <br/><br/>
Efficacy of atorvastatin for achieving cholesterol targets after LDL-cholesterol based dose selection in patients with type 2 diabetes.  [electronic resource] 

 -  Journal of cardiovascular pharmacology and therapeutics  Sep 2008 
 - 183-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1074-2484 
<br/><br/><label>Standard No.: </label>10.1177/1074248408321461  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Atorvastatin<br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Diabetes Mellitus, Type 2--complications<br/>Dose-Response Relationship, Drug<br/>Feasibility Studies<br/>Female<br/>Heptanoic Acids--administration & dosage<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--administration & dosage<br/>Hyperlipidemias--complications<br/>Male<br/>Middle Aged<br/>Pyrroles--administration & dosage<br/>Time Factors<br/>Treatment Outcome<br/>Triglycerides--blood